Simplifying Global Compliance
Alcon Slapped With Untitled Letter, FDA: Rebate Card Used Incorrectly
Washington Drug Letter
The FDA has sent an untitled letter to Novartis subsidiary Alcon Research for a rebate card that the company wrongly treated as reminder labeling.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing